About EnteraSense
EnteraSense is a company based in Galway (Ireland) founded in 2016. EnteraSense has raised $1.14 million across 3 funding rounds from investors including European Commission and European Union. EnteraSense operates in a competitive market with competitors including Prometheus Laboratories, Viome Life Sciences, NinePoint Medical, InDex Pharmaceuticals and Given Imaging, among others.
- Headquarter Galway, Ireland
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.14 M (USD)
in 3 rounds
-
Latest Funding Round
$2.85 M (USD), Grant
Jan 07, 2019
-
Investors
European Commission
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of EnteraSense
EnteraSense has successfully raised a total of $1.14M across 3 strategic funding rounds. The most recent funding activity was a Grant round of $2.85 million completed in January 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in EnteraSense
EnteraSense has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include European Commission and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Institution of the European Union responsible for upholding the EU treaties
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for EnteraSense
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by EnteraSense
Investment portfolio details for EnteraSense
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - EnteraSense
Detailed financials for EnteraSense
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Enterasense Comparisons
Peer comparison for EnteraSense
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of EnteraSense
EnteraSense operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Prometheus Laboratories, Viome Life Sciences, NinePoint Medical, InDex Pharmaceuticals and Given Imaging, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Diagnostics and therapeutics for gastrointestinal and personalized medicine are developed.
|
|
| Locked | Locked | Locked |
Provider of tests to prevent, treat, and cure chronic diseases, and cancer
|
|
| Locked | Locked | Locked |
Optical coherence tomography systems for tissue microstructure imaging are developed.
|
|
| Locked | Locked | Locked |
DNA-based immunomodulatory drugs for ulcerative colitis are developed.
|
|
| Locked | Locked | Locked |
Capsule endoscopy systems for GI imaging
|
Detailed competitors of EnteraSense
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Enterasense
Complete news archive for EnteraSense
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about EnteraSense
EnteraSense was founded in 2016 and raised its 1st funding round 3 years after it was founded.
EnteraSense is headquartered in Galway, Ireland.
EnteraSense is a funded company, having raised a total of $1.14M across 3 funding rounds to date.
Enterasense develops ingestible biosensors for GI disease. Its flagship product Sentinel is a sensor that is embedded in a capsule which is swallowed by the patient. The sensor then wirelessly transmits data to an accompanying app for the detection of bleeds in the upper GI tract.
EnteraSense's top competitors include Viome Life Sciences, Prometheus Laboratories and NinePoint Medical.
EnteraSense has 2 investors. Key investors include European Commission, and European Union.